About: Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic
Creator	Silvestris, Nicola Falzone, Luca Dellino, Miriam Guarini, Attilio Minoia, Carla Silvestris, Erica Cormio, Claudia Elasbali, Abdelbaset Loseto, Giacomo Opinto, Giuseppina Romito, Francesca
Source	Medline; PMC
abstract	Cancer patients are a population at high risk of contracting COVID-19 and, also of developing severe complications due to the infection, which is especially true when they are undergoing immunosuppressive treatment. Despite this, they had still to go to hospital to receive chemotherapy during lockdown. In this context, we have evaluated the psychological status of onco-hematological outpatients receiving infusion and not deferrable anti-neoplastic treatment for lymphoproliferative neoplasms, with the aim of both measuring the levels of post-traumatic symptoms, depression, and anxiety during the pandemic and also of investigating the perception of risk of potential nosocomial infection. The Impact of Event Scale-Revised (IES-R) and the Hospital Anxiety and Depression Scale (HADS) were administered to all patients. Moreover, patients were investigated about their worries regarding the impact of COVID-19 on their lives as onco-hematologic patients. Since the 2nd to the 29th April 2020 (during the first phase of the lockdown period in Italy), 77 outpatients were prospectively evaluated. They were diagnosed with non-Hodgkin's lymphoma, classical Hodgkin lymphoma, and Chronic lymphocytic leukemia/Small lymphocytic lymphoma. The mean age was 56.6 (range 22–85). We found that 36% of patients had anxiety (HADS-A), 31% depression (HADS-D), and 43% were above the cut-off for the HADS-General Scale; 36% fulfilled the diagnostic criteria for post-traumatic stress disorder (PTSD). Women and younger patients were found to be more vulnerable to anxiety and PTSD. The study firstly analyzes the psychological impact of the COVID-19 pandemic on the frail population of patients affected by lymphoproliferative neoplasms, to underly the importance of screening patients for emotional and distress conditions and then offering them psychological support.
has issue date	2020-07-10(xsd:dateTime)
bibo:doi	10.3389/fonc.2020.01270
bibo:pmid	32754447
has license	cc-by
sha1sum (hex)	cca59420f915536f06a4b078b2dd0e12e9c37cbb
schema:url	https://doi.org/10.3389/fonc.2020.01270
resource representing a document's title	Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic
has PubMed Central identifier	PMC7365920
has PubMed identifier	32754447
schema:publication	Front Oncol
resource representing a document's body	covid:cca59420f915536f06a4b078b2dd0e12e9c37cbb#body_text
is schema:about of	named entity 'Psychological Distress' named entity 'COVID-19 Pandemic' named entity 'anxiety' named entity 'NHL' named entity 'chemotherapy' named entity 'COVID-19' named entity 'Depression' named entity 'Student t-test' named entity 'Emilia Romagna' named entity 'European Psychiatric Association' named entity 'social distancing' named entity 'depression' named entity 'NHL' named entity 'Statistical Computing' named entity 'PTSD' named entity 'Wuhan' named entity 'chemotherapy' named entity 'infection' named entity 'COVID-19 pandemic' named entity 'post-traumatic stress' named entity 'cure rate' named entity 'classical Hodgkin lymphoma' named entity 'COVID-19 pandemic' named entity 'virus' named entity 'mental health disorders' named entity 'COVID-19 pandemic' named entity 'CLL/SLL' named entity 'opportunistic infections' named entity 'anti-neoplastic' named entity 'hyperarousal' named entity 'PTSD' named entity 'Student t-test' named entity 'NHL' named entity 'IES-R' named entity 'stress conditions' named entity 'Piemonte' named entity 'HCL' named entity 'impact of COVID-19' named entity 'PTSD' named entity 'general Chinese' named entity 'organic disease' named entity 'anxiety' named entity 'follow-up' named entity 'COVID-19' named entity 'Italy' named entity 'maintenance therapy' named entity 'Statistical significance' named entity 'PTSD' named entity 'hyperarousal' named entity 'psychological support' named entity 'psychological support' named entity 'northern Italy' named entity 'PTSD' named entity 'Giovanni Paolo II' named entity 'COVID-19 pandemic' named entity 'psychological support' named entity 'IES-R' named entity 'morbidity' named entity 'mental health problem' named entity 'Lombardia' named entity 'intravenous' named entity 'Chronic lymphocytic leukemia' named entity 'informed consent' named entity 'anxiety' named entity 'anxiety' named entity 'Italy' named entity 'higher risk' named entity 'antineoplastic' named entity 'Small lymphocytic lymphoma' named entity 'follicular lymphoma' named entity 'intensive care'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software